- Home
- CLGN vs BOWN Comparison
CLGN vs BOWN Comparison
Compare CLGN & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- BOWN
- Stock Information
- Founded
- CLGN 2004
- BOWN 2023
- Country
- CLGN Israel
- BOWN United States
- Employees
- CLGN N/A
- BOWN N/A
- Industry
- CLGN Industrial Specialties
- BOWN
- Sector
- CLGN Health Care
- BOWN
- Exchange
- CLGN Nasdaq
- BOWN Nasdaq
- Market Cap
- CLGN 37.4M
- BOWN 36.1M
- IPO Year
- CLGN N/A
- BOWN 2023
- Fundamental
- Price
- CLGN $2.58
- BOWN $7.57
- Analyst Decision
- CLGN Strong Buy
- BOWN
- Analyst Count
- CLGN 2
- BOWN 0
- Target Price
- CLGN $12.50
- BOWN N/A
- AVG Volume (30 Days)
- CLGN 12.3K
- BOWN 373.3K
- Earning Date
- CLGN 03-26-2025
- BOWN 01-01-0001
- Dividend Yield
- CLGN N/A
- BOWN N/A
- EPS Growth
- CLGN N/A
- BOWN N/A
- EPS
- CLGN N/A
- BOWN 0.39
- Revenue
- CLGN $515,000.00
- BOWN N/A
- Revenue This Year
- CLGN $2,474.76
- BOWN N/A
- Revenue Next Year
- CLGN $52.63
- BOWN N/A
- P/E Ratio
- CLGN N/A
- BOWN $20.62
- Revenue Growth
- CLGN N/A
- BOWN N/A
- 52 Week Low
- CLGN $2.54
- BOWN $2.71
- 52 Week High
- CLGN $6.75
- BOWN $11.00
- Technical
- Relative Strength Index (RSI)
- CLGN 26.97
- BOWN 64.25
- Support Level
- CLGN $2.54
- BOWN $6.50
- Resistance Level
- CLGN $3.70
- BOWN $8.89
- Average True Range (ATR)
- CLGN 0.26
- BOWN 1.04
- MACD
- CLGN -0.04
- BOWN 0.36
- Stochastic Oscillator
- CLGN 3.45
- BOWN 74.65
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.